about
NS1 specific CD8+ T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy.Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humansHigh frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.Parvovirus-B19-associated complications in renal transplant recipients.Effects of human parvovirus B19 VP1 unique region protein on macrophage responses.Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.Republished: pathogenesis and diagnosis of myocarditis.Diagnosis of in utero Parvovirus B19 infection and maternal immune response - the relevance of linear epitopes and advanced serologic testing.Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.Genotype 1 of human parvovirus B19 in clinical cases.Substitution rate and natural selection in parvovirus B19.Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease.Evaluation of the diagnostic work-up in children with myocarditis and idiopathic dilated cardiomyopathy.The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: an evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts.Persistence of human parvovirus B19 in tissues from adult individuals: a comparison with serostatus and its clinical utility.Phylogenetic evidence for the rapid evolution of human B19 erythrovirus.Development of a enterovirus diagnostic assay system for diagnosis of viral myocarditis in humans.Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.Inactivation and neutralization of parvovirus B19 Genotype 3.Autologous peripheral blood progenitor cells are a potential source of parvovirus B19 infection.Virus serology in patients with suspected myocarditis: utility or futility?Serological and molecular analysis of parvovirus B19 infection in Mayan women with systemic lupus erythematosus in Mexico.Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
P2860
Q33340287-49EE24F1-AA27-428A-837A-2B807CDB3192Q33987526-5923DE2D-9A73-43E8-9E24-AFCF5AEC87E9Q34833986-97714AB6-E74F-4384-AA33-A3929469D292Q36951683-E56EBF3A-03CC-466C-B34C-C76405D9ED3BQ37122784-938D8813-90B8-4125-B7A1-E43E85058A20Q37410780-6D6FA372-DCF7-4160-B4F5-1E086A033055Q38035826-9D610FA8-7422-4868-A552-404591311177Q38088715-91BA287B-BD12-4880-806B-A3E280EB9B9AQ39139921-B868EA84-2E50-4F4B-A6F8-5A90F7BD3B71Q40207807-A54B1B2E-C047-4261-87A7-23C4290F6E9DQ40489095-002A9752-3B8B-41AA-90F4-D2DE0F320F64Q40697247-10167C33-E6BA-4294-927B-8B5EF6FA21CEQ42192353-DE82EEB5-1254-4BB8-A352-E90288ECC73BQ42221396-F2CC4A5F-80D8-447A-B9F1-89255EF2F7F7Q42221705-615DFAFA-CBF4-4735-A5DE-554467F4373DQ43087180-0298AF00-243C-4ED6-9D43-5709A69ADE4BQ43475494-20C2847E-B2AF-433C-ABF3-2323540CC97CQ44082333-739079F8-EE89-46A1-9CD6-AB6F0478B725Q44659453-525AD42B-D62C-4B80-BBF8-DF91B9036FE0Q45307942-D6016786-A9EB-4B3D-AF27-A661AC057E65Q45369959-72304693-36B6-4851-ADE1-0B94736B52C1Q47135606-D80C1527-E2C4-4CE9-9D70-EC077DFB1D4BQ54474527-BF50FEEA-D6AD-4AB3-A54A-BE44B86A622A
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Antibody responses in parvovirus B19 infected patients.
@ast
Antibody responses in parvovirus B19 infected patients.
@en
Antibody responses in parvovirus B19 infected patients.
@nl
type
label
Antibody responses in parvovirus B19 infected patients.
@ast
Antibody responses in parvovirus B19 infected patients.
@en
Antibody responses in parvovirus B19 infected patients.
@nl
prefLabel
Antibody responses in parvovirus B19 infected patients.
@ast
Antibody responses in parvovirus B19 infected patients.
@en
Antibody responses in parvovirus B19 infected patients.
@nl
P1476
Antibody responses in parvovirus B19 infected patients.
@en
P2093
Simone Dorsch
Susanne Modrow
P304
P356
10.1016/S0369-8114(02)00302-4
P577
2002-06-01T00:00:00Z